Clinical trials of systemic therapy for operable breast cancer are evolving. Our understanding of breast cancer as a family of biologically distinct diseases has implications for patient selection and the optimization of drug choices. In addition, there is a growing dissatisfaction with trials of…
from Cancer via ola Kala on Inoreader http://ift.tt/29kFZ0W
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου